Huakang Biomedical (08622.HK) releases its interim results, with a net loss of 2.369 million yuan, representing a 33.2% increase year-on-year.

Wisdom Financial News APP, Huakang Biomedical (08622.HK) announced its performance for the six months ending June 30, 2025, with revenue of 12.329 million yuan, a year-on-year increase of 3.4%; net loss of 2.369 million yuan, a year-on-year increase of 33.2%; basic loss per share was 0.47 cents.